移植
人类免疫缺陷病毒(HIV)
医学
器官移植
器官采购
重症监护医学
肾移植
临床试验
免疫学
内科学
作者
Puja H. Nambiar,Brianna Doby,Aaron A.R. Tobian,Dorry L. Segev,Christine M. Durand
出处
期刊:Annual Review of Medicine
[Annual Reviews]
日期:2021-01-27
卷期号:72 (1): 107-118
被引量:2
标识
DOI:10.1146/annurev-med-060419-122327
摘要
Implementation of the HIV Organ Policy Equity (HOPE) Act marks a new era in transplantation, allowing organ transplantation from HIV+ donors to HIV+ recipients (HIV D+/R+ transplantation). In this review, we discuss major milestones in HIV and transplantation which paved the way for this landmark policy change, including excellent outcomes in HIV D-/R+ recipient transplantation and success in the South African experience of HIV D+/R+ deceased donor kidney transplantation. Under the HOPE Act, from March 2016 to December 2018, there were 56 deceased donors, and 102 organs were transplanted (71 kidneys and 31 livers). In 2019, the first HIV D+/R+ living donor kidney transplants occurred. Reaching the full estimated potential of HIV+ donors will require overcoming challenges at the community, organ procurement organization, and transplant center levels. Multiple clinical trials are ongoing, which will provide clinical and scientific data to further extend the frontiers of knowledge in this field.
科研通智能强力驱动
Strongly Powered by AbleSci AI